|
|
d5be66f1a6
|
astra: batch 7 — 8 space manufacturing & microgravity claims
Sync Graph Data to teleo-app / sync (push) Waiting to run
Migrated from seed package:
- Microgravity physics advantage (convection, sedimentation, container effects)
- Pharmaceutical polymorphs as novel IP mechanism
- Orbital bioprinting (tissue/organ fabrication)
- Space-based pharma manufacturing (Keytruda, Varda proof points)
- Three-tier impossible-on-Earth framework
- Varda Space Industries company analysis ($329M, 4 missions)
- ZBLAN fiber optics (submarine cable revolution)
- In-space manufacturing market projections ($62B by 2040)
Co-Authored-By: Claude Opus 4.6 (1M context) <noreply@anthropic.com>
|
2026-03-27 13:05:32 +00:00 |
|
